Design
Editorial
Answers are grounded in this paper and cite their sources.
AI-enhanced diagnostic tools offer highly sensitive screening capabilities for inherited cardiomyopathies, which could be transformative in low-resource settings like the Philippines.
I read with great interest the article by Alahwany et al., which provides a rigorous synthesis of how artificial intelligence (AI) can transform the diagnosis and management of inherited cardiomyopathies in low-resource settings [1]. The integration of machine learning (ML), deep learning (DL), and natural language processing (NLP) offers a unified framework for screening and prediction in hypertrophic (HCM), dilated (DCM), and arrhythmogenic cardiomyopathies (ACM). The reported diagnostic accuracy of AI-enhanced electrocardiograms (ECG) and point-of-care imaging, achieving sensitivities above 97% for high-risk HCM features, underscores their potential for widespread clinical use [1].
No takes yet. Share an insight, caveat, or question.
Jeff Clyde G. Corpuz (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: